James N. Topper, Director, 10% Owner at AMICUS THERAPEUTICS INC (FOLD), bought 4,740 shares at $10.19 ($49K) on 2008-03-10, disclosed to the SEC on 2008-03-10.
Open-market purchase of $49k FOLD by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.19 | 100 | $1K | 2.1% |
| 2 | $10.20 | 1,400 | $14K | 29.3% |
| 3 | $10.21 | 340 | $3K | 7.1% |
| 4 | $10.22 | 200 | $2K | 4.2% |
| 5 | $10.23 | 1,400 | $14K | 29.4% |
| 6 | $10.27 | 100 |
| $1K |
| 2.1% |
| 7 | $10.30 | 100 | $1K | 2.1% |
| 8 | $10.32 | 5 | $52 | 0.1% |
| 9 | $10.35 | 30 | $311 | 0.6% |
| 10 | $10.36 | 14 | $145 | 0.3% |
| 11 | $10.40 | 100 | $1K | 2.1% |
| 12 | $10.43 | 200 | $2K | 4.3% |
| 13 | $10.44 | 70 | $731 | 1.5% |
| 14 | $10.45 | 13 | $136 | 0.3% |
| 15 | $10.46 | 200 | $2K | 4.3% |
| 16 | $10.47 | 100 | $1K | 2.2% |
| 17 | $10.50 | 368 | $4K | 7.9% |
| Total | $10.27 avg | 4,740 | $49K | 100% |
| Filing → |
| NAMS | BUY | 2025-08-13 | $11K | — | Filing → |
| NAMS | BUY | 2025-06-26 | $69K | — | Filing → |
| NAMS | BUY | 2025-06-18 | $167K | — | Filing → |